Broker’s call: Saregama (Buy)
Target: ₹580 CMP: ₹513.10 Saregama India’s strong headline numbers masked the weakness in music licensing revenue. Consolidated revenue grew 40.3
Continue reading
Tag: Q2 performance
Broker’s call: Sun Pharma (Buy)
Target: ₹1,305 CMP: ₹1,140.75 Sun Pharmaceutical’s Q2 performance was in line with JMF/ Street estimates. Revenue growth was led by
Continue reading